Etomidate is usually presented as a clear colourless solution for injection containing 2 mg/ml of etomidate in an aqueous solution of 35% propylene glycol, although a lipid emulsion preparation (of equivalent strength) has also been introduced.
Etomidate is typically administered as either a clear, colorless solution or a lipid emulsion formulation containing 2 mg/ml of etomidate in an aqueous solution of 35% propylene glycol.